Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2003
04/10/2003WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
04/10/2003WO2003028652A2 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003WO2003028641A2 Mch receptor antagonists
04/10/2003WO2003028459A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
04/10/2003WO2003028458A1 N-thio-nicotinamide derivatives and related compounds for use as pesticides
04/10/2003WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2003WO2002076472A3 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
04/10/2003WO2002070540A3 Peptide deformylase inhibitors
04/10/2003WO2002048109A8 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators
04/10/2003WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003WO2001083800A3 Heterologous production of polyketides
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069428 Pharmaceutically active isoindoline derivatives
04/10/2003US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/10/2003US20030069284 Anticancer agent
04/10/2003US20030069276 Viricides; aids therapy
04/10/2003US20030069271 Quinolone compounds for use in treating viral infections
04/10/2003US20030069258 Novel guanidine mimics factor Xa inhibitors
04/10/2003US20030069257 Benzimidazole and pyridylimidazole derivatives
04/10/2003US20030069252 Viricides; antiinflammatory agents
04/10/2003US20030069250 Anticoagulants
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069245 Aids therapy
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069239 Anticancer agents
04/10/2003US20030069234 CXCR3 antagonists
04/10/2003US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
04/10/2003US20030069224 Non-nucleoside reverse transcriptase inhibitors
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069140 Herbicides
04/10/2003US20030066988 Electroconductivity coloring
04/10/2003CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003CA2462594A1 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
04/10/2003CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
04/10/2003CA2461381A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003CA2460594A1 Mch receptor antagonists
04/10/2003CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
04/09/2003EP1300399A1 Phenylpyridazine derivatives and drugs containing the same
04/09/2003EP1300398A1 Propane-1,3-dione derivatives
04/09/2003EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
04/09/2003EP1299390A1 Novel triazolo pyrimidine compounds
04/09/2003EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
04/09/2003EP1299379A2 Lactam metalloprotease inhibitors
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299372A1 Pyrones as inhibitors of cyclooxygenase-2
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299361A1 Pyrazole derivatives
04/09/2003EP1299360A2 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299099A2 Novel use of (r)-(-)-2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1021457B1 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1h)-ones derivatives from aminoitols, products obtained by this method and their applications
04/09/2003EP0984962B1 Substituted 4-benzoyl-pyrazoles
04/09/2003EP0946528B1 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
04/09/2003EP0934280B1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/09/2003EP0901472B1 Mercapto-imidazolyl derivatives and their use as microbicides
04/09/2003EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives
04/09/2003EP0873123B1 Inhibitors of protein isoprenyl transferases
04/09/2003EP0842155B1 Substituted aminouracils
04/09/2003EP0758327B1 Pyranone compounds useful to treat retroviral infections
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
04/09/2003CN1409703A 4-aminopiperidine derivatives and their use as medicine
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105113C Fungicidal pyrimidinones
04/09/2003CN1105109C Chloropyrimide intermediates
04/09/2003CN1104892C Method for curing tinnitus by nerve protecting agent
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
04/08/2003US6545153 Anticholesterol agents; antilipemic agents
04/08/2003US6545038 Heterocyclic metalloprotease inhibitors
04/08/2003US6545031 Carboxyalkenylpyrazolylbenzene derivatives, such as (E)-alpha-((5-(2-((2-carboxyphenyl)methoxy)-4-methoxyphenyl) -1-ethyl-1H-pyrazol-4-yl)methylene)-6-methoxy-1,3-benzodioxole -5-propanoic acid
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/08/2003US6545020 Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties
04/08/2003US6545015 Useful in therapy of bacterial infections, fungal infections
04/08/2003US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/08/2003US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
04/08/2003US6544997 E.g., hypermotility, irritable bowel syndrome, bowel hypersensitivity and the reduction of pain associated with gastrointestinal hypersensitivity and/or hyperactivity
04/08/2003US6544990 Such as N-(4-chlorobenzyl)-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide for treatment against herpes viruse; enzyme inhibitors
04/08/2003US6544981 Anticoagulants, cardiovascular disorders
04/08/2003US6544970 Administering in a first phase of a progestational agent (levonorgestrel or ethinylestradiol) and in a second phase an antiprogestin that is an indolinone derivative, especially a 3-spiroalkylene derivative
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2097824C Functionalized vinyl azoles and their use
04/08/2003CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists
04/07/2003WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
04/03/2003WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003WO2003027109A1 3-(heteroarylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027107A1 Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors
04/03/2003WO2003027105A1 Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors
04/03/2003WO2003027104A1 Fumagillol derivatives and preparing method thereof
04/03/2003WO2003027103A1 Synthesis of key azole-antifungal intermediates
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027101A1 Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
04/03/2003WO2003027100A1 Substituted 3-pyridyl pyrimidines as c17,20 lyase inhibitors
04/03/2003WO2003027098A1 Benzimidazole compound, process for producing the same, and use thereof
04/03/2003WO2003027097A1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 694